Wall Street RegretsThe regret calculator.

What if you'd held GALT?

A $1,000 investment in Galectin Therapeutics Inc. (GALT) at the month-end close of 2002-09 would be worth $226 at the close of 2026-09 — -77.4% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $14,873.

$1,000 since 2002$226Total return-77.4%Multiple0.23×CAGR-6.0%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$226Gain+$-774 (-77.4%)Multiple0.2×CAGR-6.0%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.

    2002$2262003$2652004$1952005$3072006$2522007$1,7072008$1,0982009$8,5372010$2,7442011$8542012$8002013$2,2492014$5712015$1,3292016$2,8112017$4,7042018$1,3802019$1,3442020$1,6122021$2,0582022$2,2272023$4,0802024$2,7772025$3,5742026$1,108

    Every year, $1,000 from 2002

    YearValue of $1,000Year return
    2002$1,000
    2003$1,362+36.2%
    2004$862-36.7%
    2005$1,052+22.0%
    2006$155-85.2%
    2007$241+55.6%
    2008$31.03-87.1%
    2009$96.55+211.1%
    2010$310+221.4%
    2011$331+6.7%
    2012$118-64.4%
    2013$464+294.1%
    2014$199-57.1%
    2015$94.25-52.7%
    2016$56.32-40.2%
    2017$192+240.8%
    2018$197+2.7%
    2019$164-16.6%
    2020$129-21.7%
    2021$119-7.6%
    2022$64.94-45.4%
    2023$95.40+46.9%
    2024$74.14-22.3%
    2025$239+222.5%
    2026$265+10.8%

    Best and worst month-end to buy

    The best single month-end close to have bought GALT was 2008-12 ($0.54): $1,000 then is $8,537 today. The worst was 2003-09 ($33.00): $1,000 then is $140.

    FAQ

    What would $1,000 in GALT be worth today?

    A $1,000 investment in Galectin Therapeutics Inc. (GALT) at the start of 2002 would be worth about $226 today, a total return of -77.4%. Dividends are reinvested in these figures.

    What were the best and worst years for GALT?

    Galectin Therapeutics Inc. (GALT)'s strongest calendar year since 2002 was 2013, a +294.1% return — $1,000 held through that year became about $3,941 by year-end. Its weakest year was 2008, at -87.1%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in GALT have grown?

    Investing $100 at the end of every month since 2002-09 would have grown to about $46,915 on $28,900 invested.

    Did GALT beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $14,873. GALT trailed the S&P 500 by +98.5% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Galectin Therapeutics Inc. (GALT) historical total-return data from 2002-09 to 2026-09, reduced to month-end closes for the tables above.

    Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.